POCT在临床微生物学领域中的应用

作者 | 吴文娟、高兴辉、汤一苇

仅供医学专业人士交流使用

参考文献

1. Dolen V, Bahk K, Carroll KC, Klugman K, Ledeboer NA, Miller MB. 2017. Changing Diagnostic Paradigms for Microbiology: Report on an American Academy of Microbiology Colloquium held in Washington, DC, from 17 to 18 October 2016. Washington (DC): American Society for Microbiology.

2. Egilmezer E, Walker GJ, Bakthavathsalam P, Peterson JR, Gooding JJ, Rawlinson W, Stelzer-Braid S. 2018. Systematic review of the impact of point-of-care testing for influenza on the outcomes of patients with acute respiratory tract infection. Rev Med Virol. 28(5):e1995.

3. Nitika Pant Pai, Caroline Vadnais, Claudia Denkinger, Nora Engel, Madhukar Pai. 2012. Point-of-care testing for infectious diseases: diversity, complexity, and barriers in low- and middle-income countries. PLoS Med. 9(9):e1001306.

4. Bailey AL, Ledeboer N, Burnham CD. 2019. Clinical Microbiology Is Growing Up: The Total Laboratory Automation Revolution. Clin Chem. 65(5):634-643.

5. Kozel TR, Burnham-Marusich AR. 2017. Point-of-Care Testing for Infectious Diseases: Past, Present, and Future. J Clin Microbiol. 55(8):2313-2320.

6. Miller MB, Atrzadeh F, Burnham CA, Cavalieri S, Dunn J, Jones S, Mathews C, McNult P, Meduri J, Newhouse C, Newton D, Oberholzer M, Osiecki J, Pedersen D, Sweeney N, Whitfield N, Campos J; ASM Clinical and Public Health Microbiology Committee and the ASM Corporate Council. 2019. Clinical Utility of Advanced Microbiology Testing Tools. J Clin Microbiol. 57(9):e00495-19.

7. Drancourt M, Michel-Lepage A, Boyer S, Raoult D. 2016. The Point-of-Care Laboratory in Clinical Microbiology. Clin Microbiol Rev. 29(3):429-447.

8. Clerc O, Greub G. 2010. Routine use of point-of-care tests: usefulness and application in clinical microbiology. Clin Microbiol Infect. 16(8):1054-1061.

9. 华文浩,盛琳君,王清涛.感染性疾病诊断中POCT应用的进展. 2019. 中华检验医学杂志. 42(5):333-337.

10. MacLean E, Kohli M, Weber SF, Suresh A, Schumacher SG, Denkinger CM, Pai M. 2020. Advances in Molecular Diagnosis of Tuberculosis. J Clin Microbiol. JCM.01582-19.

11. Fernández-Carballo BL, Broger T, Wyss R, Banaei N, Denkinger CM. 2019. Toward the Development of a Circulating Free DNA-Based In Vitro Diagnostic Test for Infectious Diseases: a Review of Evidence for Tuberculosis. J Clin Microbiol. 57(4):e01234-18.

12. Lessells RJ, Cooke GS, McGrath N, Nicol MP, Newell ML, Godfrey-Faussett P. 2017. Impact of Point-of-Care Xpert MTB/RIF on Tuberculosis Treatment Initiation. A Cluster-randomized Trial. Am J Respir Crit Care Med. 196(7):901-910.

13. 杨 洋，肖 盟，杨文航，张 戈，张京家，段思蒙，康 巍，王 瞳，徐英春. 2019. 现场快速检测在感染性疾病领域的应用. 中国医学装备.16卷第10期.

14. Drain PK, Dorward J, Bender A, Lillis L, Marinucci F, Sacks J, Bershteyn A, Boyle DS, Posner JD, Garrett N. 2019. Point-of-Care HIV Viral Load Testing: an Essential Tool for a Sustainable Global HIV/AIDS Response. Clin Microbiol Rev. 32(3):e00097-18.

15. Mitchell EO, Stewart G, Bajzik O, Ferret M, Bentsen C, Shriver MK. 2013. Performance comparison of the 4th generation Bio-Rad Laboratories GS HIV Combo Ag/Ab EIA on the EVOLIS™ automated system versus Abbott ARCHITECT HIV Ag/Ab Combo, Ortho Anti-HIV 1+2 EIA on Vitros ECi and Siemens HIV-1/O/2 enhanced on Advia Centaur. J Clin Virol. 58 Suppl 1:e79-84.

16. Liu L, Deng R, Lan Y, Li L, Li M, Su B, Gnanashanmugam D, Tang YW, Wu H, Wang J, Cai X, Zhang T. Multicenter evaluation of Xpert HIV-1 viral load assay for HIV quantification in China. 2020. J Med Virol.

17. Nosyk B, Montaner JSG, Colley G, Lima VD, Chan K, Heath K, Yip B, Samji H, Gilbert M, Barrios R, Gustafson R, Hogg RS; STOP HIV/AIDS Study Group. 2014. The cascade of HIV care in British Columbia, Canada, 1996-2011: a population-based retrospective cohort study. Lancet Infect Dis. 14(1):40-49.

18. Berry GJ, Miller CR, Prats MM, Marquez C, Oladipo OO, Loeffelholz MJ, Petersen JR. 2018. Comparison of the Alere i Strep A Test and the BD Veritor System in the Detection of Group A Streptococcus and the Hypothetical Impact of Results on Antibiotic Utilization. J Clin Microbiol. 56(3):e01310-17.

19. Thompson TZ, McMullen AR. 2020. Group A Streptococcus Testing in Pediatrics: the Move to Point-of-Care Molecular Testing. J Clin Microbiol. 58(6):e01494-19.

20. Ralph AP, Holt DC, Islam S, Osowicki J, Carroll DE, Tong SYC, Bowen AC. 2019. Potential for Molecular Testing for Group A Streptococcus to Improve Diagnosis and Management in a High-Risk Population: A Prospective Study. Open Forum Infect Dis. 6(4):ofz097.

21. 吴文娟.感染性疾病现场快速检验技术的现状与未来. 2018. 中华检验医学杂志. 41(9):641-643.

22. Giraud-Gatineau A, Colson P, Jimeno MT, Zandotti C, Ninove L, Boschi C, Lagier JC, La Scola B, Chaudet H, Raoult D. 2020. Comparison of mortality associated with respiratory viral infections between December 2019 and March 2020 with that of the previous year in Southeastern France. Int J Infect Dis. 96:154-156.

23. Blaschke AJ, Shapiro DJ, Pavia AT, Byington CL, Ampofo K, Stockmann C, Hersh AL. 2014. A National Study of the Impact of Rapid Influenza Testing on Clinical Care in the Emergency Department. J Pediatric Infect Dis Soc. 2014. 3(2):112-118.

24. Vecino-Ortiz AI, Goldenberg SD, Douthwaite ST, Cheng CY, Glover RE, Mak C, Adams EJ. 2018. Impact of a multiplex PCR point-of-care test for influenza A/B and respiratory syncytial virus on an acute pediatric hospital ward. Diagn Microbiol Infect Dis. 91(4):331-335.

25. Tang YW, Schmitz JE, Persing DH, Stratton CW. 2020. Laboratory Diagnosis of COVID-19: Current Issues and Challenges. J Clin Microbiol. 26;58(6):e00512-20.

26. Banerjee D, Kanwar N, Hassan F, Essmyer C, Selvarangan R. 2018. Comparison of Six Sample-to-Answer Influenza A/B and Respiratory Syncytial Virus Nucleic Acid Amplification Assays Using Respiratory Specimens from Children. J Clin Microbiol. 56(11):e00930-18.

27. Zhen W, Smith E, Manji R, Schron D, Berry GJ. 2020. Clinical Evaluation of Three Sample-to-Answer Platforms for Detection of SARS-CoV-2. J Clin Microbiol. 58(8):e00783-20.

28. Azar MM, Landry ML. 2018. Detection of Influenza A and B Viruses and Respiratory Syncytial Virus by Use of Clinical Laboratory Improvement Amendments of 1988 (CLIA)-Waived Point-of-Care Assays: a Paradigm Shift to Molecular Tests. J Clin Microbiol. 56(7):e00367-18.

29. Ling L, Kaplan SE, Lopez JC, Stiles J, Lu X, Tang YW. 2018. Parallel Validation of Three Molecular Devices for Simultaneous Detection and Identification of Influenza A and B and Respiratory Syncytial Viruses. J Clin Microbiol. 56(3):e01691-17.